Evaluation of shorter versus longer antifungal treatment durations for Candida spp. urinary tract infections among hospitalized adults
- PMID: 40261002
- PMCID: PMC12135507
- DOI: 10.1128/aac.01920-24
Evaluation of shorter versus longer antifungal treatment durations for Candida spp. urinary tract infections among hospitalized adults
Abstract
Infectious Diseases Society of America guidelines recommend 14 days of treatment for Candida spp. urinary tract infections (UTIs). To our knowledge, no data are available to compare <14 days for Candida spp. UTI. This was a single-center, retrospective cohort study between 01 January 2015 and 01 January 2024. Hospitalized adults with
Keywords: Candida; antifungal; duration; fluconazole; urinary tract infection.
Conflict of interest statement
W.D.K. discloses research funding from Melinta Therapeutics and Merck and Co., consultation honoraria from Shionogi, Inc., and is on an advisory board at Theratechnologies. E.A.A.-R. has received funds from Abbvie, GSK, and Theratechnologies for studies on which she is an investigator. All other authors have nothing to disclose.
References
-
- Kauffman CA, Vazquez JA, Sobel JD, Gallis HA, McKinsey DS, Karchmer AW, Sugar AM, Sharkey PK, Wise GJ, Mangi R, Mosher A, Lee JY, Dismukes WE, National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group . 2000. Prospective multicenter surveillance study of funguria in hospitalized patients. Clin Infect Dis 30:14–18. doi:10.1086/313583 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
